{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:17:45Z","timestamp":1791883065996,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Luzhou Municipal People's Government-Southwest Medical University Science and Technology Strategic Cooperation Fund","award":["No. 2020LZXNYDJ12"],"award-info":[{"award-number":["No. 2020LZXNYDJ12"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-023-10013-7","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T01:02:56Z","timestamp":1692234176000},"page":"1077-1085","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Performance of [18F]FDG PET\/CT versus FAPI PET\/CT for lung cancer assessment: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"34","author":[{"given":"Qiuya","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoshu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YuanHang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haodong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0643-8527","authenticated-orcid":false,"given":"Ping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,17]]},"reference":[{"issue":"1","key":"10013_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE et al (2022) (2022) Cancer statistics. CA Cancer J Clin 72(1):7\u201333","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10013_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomatarm I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10013_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10013_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.annonc.2021.09.008","volume":"33","author":"JL Dickson","year":"2022","unstructured":"Dickson JL, Horst C, Nair A et al (2022) Hesitancy around low-dose CT screening for lung cancer. Ann Oncol 33(1):34\u201341","journal-title":"Ann Oncol"},{"key":"10013_CR5","doi-asserted-by":"publisher","first-page":"106111","DOI":"10.1016\/j.cmpb.2021.106111","volume":"206","author":"SP Morozov","year":"2021","unstructured":"Morozov SP, Gombolevskiy VA, Elizarov AB et al (2021) A simplified cluster model and a tool adapted for collaborative labeling of lung cancer CT scans. Comput Methods Programs Biomed 206:106111","journal-title":"Comput Methods Programs Biomed"},{"issue":"6","key":"10013_CR6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMoa1911793","volume":"382","author":"HJ de Koning","year":"2020","unstructured":"de Koning HJ, van der Aalst CM, de Jong PA et al (2020) Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med 382(6):503\u2013513","journal-title":"N Engl J Med"},{"issue":"6","key":"10013_CR7","doi-asserted-by":"publisher","first-page":"8538","DOI":"10.3934\/mbe.2021423","volume":"18","author":"X Zhang","year":"2021","unstructured":"Zhang X, Yu Z (2021) Pathological analysis of hesperetin-derived small cell lung cancer by artificial intelligence technology under fiberoptic bronchoscopy. Math Biosci Eng 18(6):8538\u20138558","journal-title":"Math Biosci Eng"},{"issue":"9181","key":"10013_CR8","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/S0140-6736(99)02824-X","volume":"354","author":"SJ Skehan","year":"1999","unstructured":"Skehan SJ, Issenman R, Mernagh J et al (1999) 18F-fluorodeoxyglucose positron tomography in diagnosis of paediatric inflammatory bowel disease. Lancet 354(9181):836\u2013837","journal-title":"Lancet"},{"issue":"10","key":"10013_CR9","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1001\/jama.1988.03720100049037","volume":"259","author":"Instrumentation in positron emissio","year":"1988","unstructured":"Instrumentation in positron emission tomography. Council on Scientific Affairs, (1988) Report of the Positron Emission Tomography Panel. JAMA 259(10):1531\u20131536","journal-title":"JAMA"},{"issue":"9388","key":"10013_CR10","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/S0140-6736(03)14366-8","volume":"362","author":"AM Scharko","year":"2003","unstructured":"Scharko AM, Perlman SB, Pyzalski RW et al (2003) Whole-body positron emission tomography in patients with HIV-1 infection. Lancet 362(9388):959\u2013961","journal-title":"Lancet"},{"issue":"3","key":"10013_CR11","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1200\/JCO.1996.14.3.700","volume":"14","author":"M Findlay","year":"1996","unstructured":"Findlay M, Young H, Cunningham D et al (1996) Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil. J Clin Oncol 14(3):700\u2013708","journal-title":"J Clin Oncol"},{"issue":"1","key":"10013_CR12","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1164\/ajrccm.153.1.8542152","volume":"153","author":"DA Sazon","year":"1996","unstructured":"Sazon DA, Santiago SM, Soo Hoo GW et al (1996) Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer. Am J Respir Crit Care Med 153(1):417\u2013421","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10013_CR13","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1200\/JCO.1999.17.8.2381","volume":"17","author":"H Schirrmeister","year":"1999","unstructured":"Schirrmeister H, Guhlmann A, Kotzerke J et al (1999) Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. J Clin Oncol 17(8):2381\u20132389","journal-title":"J Clin Oncol"},{"key":"10013_CR14","doi-asserted-by":"crossref","unstructured":"Lee JW, O JH, Choi M, Choi JY (2020) Impact of F-18 fluorodeoxyglucose PET\/CT and PET\/MRI on initial staging and changes in management of pancreatic ductal adenocarcinoma: a systemic review and meta-analysis. Diagnostics (Basel) 10(11):952","DOI":"10.3390\/diagnostics10110952"},{"issue":"3","key":"10013_CR15","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.athoracsur.2004.02.067","volume":"78","author":"RJ Cerfolio","year":"2004","unstructured":"Cerfolio RJ, Ojha B, Bryant AS et al (2004) The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg\n78(3):1017\u20131023","journal-title":"Ann Thorac Surg"},{"issue":"10","key":"10013_CR16","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.6004\/jnccn.2018.0079","volume":"16","author":"GP Kalemkerian","year":"2018","unstructured":"Kalemkerian GP, Loo BW, Akerley W et al (2018) NCCN guidelines insights: small cell lung cancer, Version 2.2018. J Natl Compr Canc Netw 16(10):1171\u20131182","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"10013_CR17","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1159\/000074207","volume":"70","author":"J Konishi","year":"2003","unstructured":"Konishi J, Yamazaki K, Tsukamoto E et al (2003) Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings. Respiration 70(5):500\u2013506","journal-title":"Respiration"},{"issue":"1","key":"10013_CR18","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.lungcan.2007.08.036","volume":"60","author":"N Al-Sarraf","year":"2008","unstructured":"Al-Sarraf N, Gately K, Lucey J et al (2008) Lymph node staging by means of positron emission tomography is less accurate in non-small cell lung cancer patients with enlarged lymph nodes: analysis of 1,145 lymph nodes. Lung Cancer 60(1):62\u201368","journal-title":"Lung Cancer"},{"key":"10013_CR19","doi-asserted-by":"publisher","first-page":"924223","DOI":"10.3389\/fonc.2022.924223","volume":"12","author":"J Wu","year":"2022","unstructured":"Wu J, Deng H, Zhong H et al (2022) Comparison of (68)Ga-FAPI and (18)F-FDG PET\/CT in the evaluation of patients with newly diagnosed non-small cell lung cancer. Front Oncol 12:924223","journal-title":"Front Oncol"},{"issue":"1","key":"10013_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2967\/jnumed.115.162040","volume":"57","author":"MW Huellner","year":"2016","unstructured":"Huellner MW, de Galiza BF, Husmann L et al (2016) TNM staging of non-small cell lung cancer: comparison of PET\/MR and PET\/CT. J Nucl Med 57(1):21\u201326","journal-title":"J Nucl Med"},{"issue":"9","key":"10013_CR21","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R (2016) The biology and function of fibroblasts in cancer. Nat Rev Cancer 16(9):582\u2013598","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"10013_CR22","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s12094-021-02734-2","volume":"24","author":"S Kamali Zonouzi","year":"2022","unstructured":"Kamali Zonouzi S, Pezeshki PS, Razi S et al (2022) Cancer-associated fibroblasts in colorectal cancer. Clin Transl Oncol 24(5):757\u2013769","journal-title":"Clin Transl Oncol"},{"issue":"9","key":"10013_CR23","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1111\/febs.15851","volume":"289","author":"Y Mezawa","year":"2022","unstructured":"Mezawa Y, Orimo A (2022) Phenotypic heterogeneity, stability and plasticity in tumor-promoting carcinoma-associated fibroblasts. FEBS J 289(9):2429\u20132447","journal-title":"FEBS J"},{"issue":"9","key":"10013_CR24","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.2967\/jnumed.119.237016","volume":"61","author":"SA Koerber","year":"2020","unstructured":"Koerber SA, Staudinger F, Kratochwil C et al (2020) The role of (68)Ga-FAPI PET\/CT for patients with malignancies of the lower gastrointestinal tract: first clinical experience. J Nucl Med 61(9):1331\u20131336","journal-title":"J Nucl Med"},{"issue":"12","key":"10013_CR25","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1007\/s00259-019-04444-y","volume":"46","author":"M R\u00f6hrich","year":"2019","unstructured":"R\u00f6hrich M, Loktev A, Wefers AK et al (2019) IDH-wildtype glioblastomas and grade III\/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET\/CT. Eur J Nucl Med Mol Imaging 46(12):2569\u20132580","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10013_CR26","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1007\/s00259-022-06021-2","volume":"50","author":"D Huang","year":"2023","unstructured":"Huang D, Wu J, Zhong H et al (2023) [(68)Ga]Ga-FAPI PET for the evaluation of digestive system tumors: systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 50(3):908\u2013920","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"10013_CR27","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1007\/s00259-022-05818-5","volume":"49","author":"X Zhou","year":"2022","unstructured":"Zhou X, Wang S, Xu X et al (2022) Higher accuracy of [(68) Ga]Ga-DOTA-FAPI-04 PET\/CT comparing with 2-[(18)F]FDG PET\/CT in clinical staging of NSCLC. Eur J Nucl Med Mol Imaging 49(8):2983\u20132993","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10013_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1148\/radiol.211424","volume":"303","author":"L Wang","year":"2022","unstructured":"Wang L, Tang G, Hu K et al (2022) Comparison of (68)Ga-FAPI and (18)F-FDG PET\/CT in the evaluation of advanced lung cancer. Radiology 303(1):191\u2013199","journal-title":"Radiology"},{"issue":"4","key":"10013_CR29","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1001\/jama.2017.19163","volume":"319","author":"MDF McInnes","year":"2018","unstructured":"McInnes MDF, Moher D, Thombs BD et al (2018) Preferred Reporting Items for a Systematic Review and Meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA Statement. JAMA 319(4):388\u2013396","journal-title":"JAMA"},{"issue":"8","key":"10013_CR30","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155(8):529\u2013536","journal-title":"Ann Intern Med"},{"issue":"11","key":"10013_CR31","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539\u20131558","journal-title":"Stat Med"},{"issue":"7414","key":"10013_CR32","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557\u2013560","journal-title":"BMJ"},{"key":"10013_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12874-015-0024-z","volume":"15","author":"PT von Hippel","year":"2015","unstructured":"von Hippel PT (2015) The heterogeneity statistic I(2) can be biased in small meta-analyses. BMC Med Res Methodol 15:35","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"10013_CR34","doi-asserted-by":"publisher","first-page":"386","DOI":"10.2967\/jnumed.118.215913","volume":"60","author":"FL Giesel","year":"2019","unstructured":"Giesel FL, Kratochwil C, Lindner T et al (2019) (68)Ga-FAPI PET\/CT: biodistribution and preliminary dosimetry estimate of 2 DOTA-containing FAP-targeting agents in patients with various cancers. J Nucl Med 60(3):386\u2013392","journal-title":"J Nucl Med"},{"issue":"2","key":"10013_CR35","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s11307-021-01679-w","volume":"24","author":"Y Li","year":"2022","unstructured":"Li Y, Lin X, Li Y et al (2022) Clinical utility of F-18 labeled fibroblast activation protein inhibitor (FAPI) for primary staging in lung adenocarcinoma: a prospective study. Mol Imaging Biol 24(2):309\u2013320","journal-title":"Mol Imaging Biol"},{"issue":"4","key":"10013_CR36","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/1759-7714.12981","volume":"10","author":"L Zhu","year":"2019","unstructured":"Zhu L, Yin G, Chen W et al (2019) Correlation between EGFR mutation status and F(18) -fluorodeoxyglucose positron emission tomography-computed tomography image features in lung adenocarcinoma. Thorac Cancer 10(4):659\u2013664","journal-title":"Thorac Cancer"},{"issue":"4","key":"10013_CR37","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1378\/chest.13-0073","volume":"144","author":"ZM Li","year":"2013","unstructured":"Li ZM, Ding ZP, Luo QQ et al (2013) Prognostic significance of the extent of lymph node involvement in stage II-N1 non-small cell lung cancer. Chest 144(4):1253\u20131260","journal-title":"Chest"},{"issue":"4","key":"10013_CR38","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1007\/s00259-020-05055-8","volume":"48","author":"S Serfling","year":"2021","unstructured":"Serfling S, Zhi Y, Schirbel A et al (2021) Improved cancer detection in Waldeyer\u2019s tonsillar ring by (68)Ga-FAPI PET\/CT imaging. Eur J Nucl Med Mol Imaging 48(4):1178\u20131187","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"10013_CR39","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1097\/MNM.0000000000001607","volume":"43","author":"C Can","year":"2022","unstructured":"Can C, Kepenek F, K\u00f6mek H et al (2022) Comparison of 18 F-FDG PET\/CT and 68 Ga-FAPI-04 PET\/CT in patients with non-small cell lung cancer. Nucl Med Commun 43(10):1084\u20131091","journal-title":"Nucl Med Commun"},{"issue":"5","key":"10013_CR40","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/s00259-021-05638-z","volume":"49","author":"Y Wei","year":"2022","unstructured":"Wei Y, Cheng K, Fu Z et al (2022) [(18)F]AlF-NOTA-FAPI-04 PET\/CT uptake in metastatic lesions on PET\/CT imaging might distinguish different pathological types of lung cancer. Eur J Nucl Med Mol Imaging 49(5):1671\u20131681","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-10013-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-023-10013-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-10013-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T06:05:55Z","timestamp":1707372355000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-023-10013-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,17]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["10013"],"URL":"https:\/\/doi.org\/10.1007\/s00330-023-10013-7","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,17]]},"assertion":[{"value":"31 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Ping Zhou.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Delong Huang kindly provided statistical advice for this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was not required for this study because we statistically analyzed other people\u2019s experiments and it was registered with PROSPERO9 (CRD42022374792; available at\n                      \n                      ).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was not required because it was a systematic review and meta-analysis.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Some study subjects or cohorts have not been previously reported.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"value":"\u2022 prospective\u2022 diagnostic study\u2022 Performed at one institution","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology and design-location"}}]}}